CYP17 and CYP19 genetic variants are not associated with age at natural menopause in Polish women

Reproductive Biology

Volumn 12, Issue 4, 2012, Pages 368-373

  Rumianowski, Bogdan ^a   Adler, Grazyna ^a   Safranow, Krzysztof ^a   Brodowska, Agnieszka ^a   Karakiewicz, Beata ^a   Słuczanowska Głabowska, Sylwia ^a   Łoniewska, Beata ^a   Piasecka, Małgorzata ^a   Ciechanowicz, Andrzej ^a   Laszczyńska, Maria ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Estrogen biosynthesis; Genetic polymorphism; Menopause

Indexed keywords

EID: 84870995108     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repbio.2012.10.011     Document Type: Article

References (39)

1. World Health Organization Scientific Group Research on the menopause in the 1990s. WHO Technical Services Department series no. 866. Geneva: WHO; 1996.
2. Brodowska A, Laszczyńska M, Starczewski A, Brodowski J, Masiuk M, Domagała W. Immunohistochemical analysis of steroid receptors in ovaries of postmenopausal women - effect of aging and hormone status. Histology and Histopathology 2010;25:1009-10.
3. Laszczyńska M, Brodowska A, Starczewski A, Masiuk M, Brodowski J. Human postmenopausal ovary - hormonally inactive fibrous connective tissue or more? Histology and Histopathology 2008;23:219-220.
4. Kok HS, Van Asselt KM, Van Der Schouw YT, Peeters PH, Wijmenga C. Genetic studies to identify genes underlying menopausal age. Human Reproduction Update 2005;11: 483-90.
5. Kaczmarek M. The timing of natural menopause in Poland and associated factors. Maturitas 2007;57:139-40.
6. Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, et al. Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis 2008;29:766-70.
7. Hefler LA, Grimm C, Heinze G, Schneeberger C, Mueller MW, Muendlein A, et al. Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Human Reproduction 2005;20:1422-30.
8. Parazzini F. Determinants of age at natural menopause in women attending menopause clinics in Italy. Maturitas 2007;56:280-90.
9. Gold EB, Bromberger J, Crawford S, Samuels S, Greendale GA, Harlow SD, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. American Journal of Epidemiology 2001;153:865-70.
10. Murabito JM, Yang Q, Fox C, Wilson PW, Cupples LA. Heritability of age at natural menopause in the Framingham Heart Study. Journal of Clinical Endocrinology and Metabolism 2005;90:3427-30.
11. Van Asselt KM, Kok HS, Pearson PL, Dubas JS, Peeters PH, Te Welde ER, et al. Heritability of menopausal age in mothers and daughters. Fertility and Sterility 2004;82:1348-50.
12. Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Research 2007;67:1893-900.
13. Kok HS, Onland-Moret NC, Van Asselt KM, Van Gils CH, Van der Schouw YT, Grobbee DE, et al. No association of estrogen receptor alpha and cytochrome P450c17alpha polymorphisms with age at menopause in a Dutch cohort. Human Reproduction 2005;20:536-40.
14. Haiman CA, Hankinson SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, et al. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. International Journal of Cancer 2000;87:204-10.
15. Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. A polymorphism in CYP17 and endometrial cancer risk. Cancer Research 2001;61:3955-60.
16. Tworger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiology Biomarkers and Prevention 2004;13:94-100.
17. Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, et al. Association of genetic polymorphisms of ER-a and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Research and Treatment 2009;114:327-30.
18. Chambo D, Kemp C, Costa AMM, Souza NCN, Guerreiro da Silva IDC. Polymorphism in CYP17, GSTM1 and the progesterone receptor genes and its relationship with mammographic density. Brazilian Journal of Medical and Biological Research 2009;42:323-30.
19. Rumianowski B, Laszczyńska M, Brodowska A, Piasecka M, Karakiewicz B. Genetic polymorphism of the estrogen biosynthesis pathway key enzymes in women. Poste{ogonek}py Biologii Komórki 2010;37:1-16.
20. Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, et al. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients. Journal of Human Genetics 2007;52:159-60.
21. García-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF. Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in premenopausal women. International Journal of Cancer 2002;102:172-80.
22. Carreau S, Lambard S, Delalande C, Denis-Galeraud I, Bilinska B, Bourguiba S. Aromatase expression and role of estrogens in male gonad: a review. Reproductive Biology and Endocrinology 2003;11:1-35.
23. Goodman MT, Lurie G, Thompson PJ, McDuffie KE, Carney ME. Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk. Endocrine-related Cancer 2008;15:1055-60.
24. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Journal of the National Cancer Institute 2005;97:153-60.
25. Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, et al. Association of the CYP17 gene and the CYP19 gene polymorphism with risk of endometriosis in Japanese women. Human Reproduction 2002;17:897-900.
26. Guo SW, Thompson EA. Performing the exact test of Hardy- Weinberg proportion for multiple alleles. Biometrics 1992;48:361-70.
27. Heil W, Koberstein R, Zawta B. Reference ranges for adults and children: pre-analytical considerations. Mannheim: Roche Diagnostics GmbH; 2004.
28. Nakano R, Shima K, Yamoto M, Kobayashi M, Nishimori K, Hiraoka J. Binding sites for gonadotropins in human postmenopausal ovaries. Obstetrics and Gynecology 1984;73:196-200.
29. Kulik-Rechberger B, Skorupski P, Bogusiewicz, Miotła P, Rechberger T. Polymorphism of CYP17 gene and age of menarche. Ginekologia Polska 2007;78:929-30.
30. Sobczuk A, Romanowicz H, Fiks T, Połać I, Smolarz B. The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer. Polish Journal of Pathology 2009;60:163-70.
31. Sharp L, Cardy AH, Cotton SC, Little J. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. A huge review. American Journal of Epidemiology 2004;160:729-30.
32. Gorai I, Tanaka K, Inada M, Morinaga H, Uchiyama Y, Kikuchi R, et al. Estrogen metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. Journal of Clinical Endocrinology and Metabolism 2003;88:799-800.
33. Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, et al. CYP17 genetic polymorphism, breast cancer and breast cancer risk factors. Breast Cancer Research 2003;5:45-50.
34. Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL. A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 1998;8:43-8.
35. Gennari L, Masi L, Merlotti D, Picariello L, Falchetti A, Tanini A, et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. Journal of Clinical Endocrinology and Metabolism 2004;89:2803-10.
36. Letonja M, Peterlin B, Bregar D, Petrovič D. Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in caucasians? Folia Biologica 2005;51:76-80.
37. Masi L, Becherini L, Gennari L, Amedei A, Colli E, Falchetti A, et al. Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. Journal of Clinical Endocrinology and Metabolism 2001;86:2263-70.
38. Mitchell ES, Farin FM, Stapleton PL, Tsai JM, Tao EY, Smith-DiJulio K, et al. Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause 2008;15:105-10.
39. Moron FJ, Ruiz A, Galan JJ. Genetic and genomic insights into age at natural menopause. Genome Medicine 2009;76:1-4.